Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.
AUTHORS
- NIHMSID: 9100846
ABSTRACT
Several observational studies suggest that metformin reduces incidence cancer risk; however, many of these studies suffer from time-related biases and several cancer outcomes have not been investigated due to small sample sizes.
Several observational studies suggest that metformin reduces incidence cancer risk; however, many of these studies suffer from time-related biases and several cancer outcomes have not been investigated due to small sample sizes.
Tags: Faculty Publications 2018